Procter & Gamble stock rises as sales and earnings stay resilient

Procter & Gamble stock is anchored by fiscal 2025 net sales of $84.3 billion, core earnings per share of $6.83, and operating cash flow of $16.0 billion. The company also reported diluted net earnings per share of $6.51 for fiscal 2025, all from its latest annual reporting context.

Fiscal 2025 numbers

Procter & Gamble reported fiscal 2025 net sales of $84.3 billion, down 2% from the prior year, while organic sales rose 2%. Core EPS reached $6.83 for the year, up 4% versus fiscal 2024, which gives the share story a clear earnings base.

Operating cash flow came in at $16.0 billion in fiscal 2025, and free cash flow productivity reached 95%. That combination matters because it shows the consumer staples group still converts profit into cash at a high rate even in a slower growth year.

Margin and cash flow

Gross margin stood at 51.2% in fiscal 2025, while adjusted free cash flow productivity was 95%. The gap between a 2% reported sales decline and 2% organic growth points to the impact of currency and portfolio mix rather than a sharp deterioration in demand.

Diluted net earnings per share of $6.51 for fiscal 2025 versus core EPS of $6.83 also shows the effect of non-core items. For investors, the spread between those two figures matters because it helps separate underlying operating strength from accounting noise.

Guidance and scale

For fiscal 2026, Procter & Gamble guided to all-in sales growth of flat to up 4% and core EPS growth of flat to up 4%. That range is important because it frames the next year against fiscal 2025 net sales of $84.3 billion and core EPS of $6.83.

The company also ended fiscal 2025 with market capitalization as a useful anchor for the scale of the equity story, even when a live quote is not part of this article. Procter & Gamble remains a large-cap consumer staples name with cash generation as the central valuation driver.

Personal care demand

Within the portfolio, Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care remain the core categories. The company said fiscal 2025 organic sales growth reflected a mixed consumer backdrop across those segments, with pricing, mix, and volume each contributing differently through the year.

Closing level

Procter & Gamble shares trade on the New York Stock Exchange in USD. The article uses fiscal 2025 figures as the main evidence set, with the latest published annual numbers defining the current financial backdrop for the stock.